Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.3%

3 terminated out of 130 trials

Success Rate

93.8%

+7.2% vs benchmark

Late-Stage Pipeline

8%

10 trials in Phase 3/4

Results Transparency

2%

1 of 45 completed with results

Key Signals

1 with results94% success

Data Visualizations

Phase Distribution

90Total
Not Applicable (64)
Early P 1 (2)
P 1 (8)
P 2 (6)
P 3 (5)
P 4 (5)

Trial Status

Completed45
Recruiting26
Not Yet Recruiting26
Unknown19
Active Not Recruiting6
Enrolling By Invitation3

Trial Success Rate

93.8%

Benchmark: 86.6%

Based on 45 completed trials

Clinical Trials (130)

Showing 20 of 20 trials
NCT07675551Not ApplicableRecruitingPrimary

Peel Family Diabetes Prevention Program

NCT07847294Not ApplicableRecruitingPrimary

The Effectiveness of an Occupation-Based Lifestyle Program in Individuals With Type 2 Diabetes

NCT07840807Completed

Traditional Chinese Medicine Fasting Therapy, Ketone Levels, and Metabolic Improvements

NCT07837856Not ApplicableCompleted

Therapeutic Adherence in Type 2 Diabetes

NCT04940962Not ApplicableCompletedPrimary

Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion

NCT07348809Not ApplicableCompletedPrimary

The Effects Of Virtual Reality and Stress Ball Application on Pain, Anxiety Levels and Injection Satisfaction in During Insulin Injection in Geriatric Patients With Type 2 Diabetes

NCT07820722Early Phase 1Not Yet RecruitingPrimary

Assessing Heart and Brain Metabolism in Type II Diabetes Mellitus Patients Using Carbon-13 MRI

NCT07794254Phase 1Not Yet Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 2 Diabetes Mellitus

NCT07471802Active Not RecruitingPrimary

Monitoring of the Sympathetic/Vagal Balance Through Multiparametric Analysis of Heart Rate Variability (HRV)

NCT05987410Not ApplicableRecruiting

EffectiVenEss of a Rehabilitation Treatment With Nordic Walking in obEse or oveRweight Patients

NCT07344324Not ApplicableNot Yet RecruitingPrimary

Study Evaluating the Safety and Feasibility of Endoscopic Duodenal Injections of Autologous Mesenchymal Stem Cells

NCT07739537Phase 4Not Yet RecruitingPrimary

PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses

NCT07788378CompletedPrimary

Metformin in Elderly Patients With Type 2 Diabetes and Muscle Strength, Muscle Mass, and Physical Function: Positive or Negative Correlation?

NCT07563699Phase 1RecruitingPrimary

Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus

NCT07338331Not ApplicableCompletedPrimary

Comparative Effects of Aspirin, Metformin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease

NCT04887077Not ApplicableCompleted

Digital Intervention Promoting Physical Activity Among Obese People (DIPPAO)

NCT07734428Not Yet Recruiting

Inflammation and Diabetes: Evaluating Antioxidant Levels

NCT07730567Phase 1Not Yet Recruiting

A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B

NCT07713836Not ApplicableNot Yet RecruitingPrimary

Nutrition Intervention Optimization to Better Utilize Resources and Support Health

NCT07693296Not ApplicableRecruitingPrimary

Type 2 Diabetes Mellitus and Downhill Aerobic Exercise Training

Scroll to load more

Research Network

Activity Timeline